4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-055362
EVP and General Counsel sold 7,336 shares at $100.65 ($738,368)
- EVP and General Counsel acquired 7,336 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-08 | Exercise or conversion : show line 1 in the form | +7,336 | $54.50 | $399,812 | 36,004 | D |
| 2021-09-08 | Sale : show line 2 in the form | −7,336 | $100.65 | $738,368 | 28,668 | D |
| Open-market sales · 7,336 sh · avg $100.65 · $738,368 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-08 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,336 | 17,664 | D |
Loading xslF345X03/doc4.xml…